𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Low dose cytosine arabinoside (Ara C) in myelodysplastic syndromes

✍ Scribed by G. Tricot; R. De Bock; A. W. Dekker; M. A. Boogaerts; M. Peetermans; K. Punt; R. L. Verwilghen

Book ID
114710327
Publisher
John Wiley and Sons
Year
1984
Tongue
English
Weight
512 KB
Volume
58
Category
Article
ISSN
0007-1048

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

The cytosine arabinoside (Ara-C) syndrom
The cytosine arabinoside (Ara-C) syndrome
✍ Castleberry, R. P. ;Crist, William M. ;Holbrook, Tate ;Malluh, Ahmad ;Gaddy, Deb πŸ“‚ Article πŸ“… 1981 πŸ› John Wiley and Sons 🌐 English βš– 404 KB

## Abstract Four patients with non‐Hodgkin lymphoma and two with acute lymphocytic leukemia (ages 4 years 4 months to 16 years 6 months) exhibited a unique reaction to intravenously administered cytosine arabinoside (Ara‐C) given alone as a part of the previously reported LSA~2~‐L~2~ treatment prot

Low-dose cytosine arabinoside in the mye
Low-dose cytosine arabinoside in the myelodysplastic syndromes and acute myelogenous leukemia
✍ J. D. Roberts; W. B. Ershler; B. H. Tindle; J. A. Stewart πŸ“‚ Article πŸ“… 1985 πŸ› John Wiley and Sons 🌐 English βš– 351 KB πŸ‘ 2 views

Seven patients with a myelodysplastic syndrome or "smoldering" acute myelogenous leukemia were treated with cytosine arabinoside in low dosage. Four patients experienced transient, partial responses characterized by improved peripheral blood counts, cessation of transfusion requirements, and a decre